The Spitterati and Trickle-Down Genomics
By Marcy Darnovsky,
Mother Jones blog
| 11. 03. 2008
Just before the world's financial system hit the skids, the New Yorker's Talk of the Town and the New York Times' Sunday Styles section both featured lengthy accounts of a celebrity "spit party," at which notables in cocktail attire ejected their saliva into test tubes. The chic gala, hosted by media moguls Barry Diller, Rupert Murdoch, and Harvey Weinstein, was the latest episode of a remarkable publicity push by 23andMe, the start-up biotech firm whose mission is "to be the world's trusted source of personal genetic information."
The Google-backed company launched its celebrity strategy this past January, when it distributed a thousand free spit kits at the elite World Economic Forum in Davos, Switzerland. But the genomes of the rich and famous were just the first step. Early this fall, 23andMe announced that it's slashing its prices to Christmas-stocking levels, in a bid to make DNA tests this year's high-tech must-have.
This is shrewd promotion. Though the spreading economic gloom may put a ding in sales of $399 spit kits, 23andMe remains on a media roll. The company has...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
